Clinical Trial Update: Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a targeted therapy in incurable non-small cell lung cancer with EGFR mutations; the study was terminated and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: EGFR Activating Mutation, Recurrent Non-Small Cell Lung Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2024-06-28